The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

The same is true with other popular medicines such as psoriasis treatment Otezla, blood thinner Xarelto and generic versions of the cancer drug Tykerb, known as lapatinib, which has 460 prices ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic equivalents to name-brand rivaroxaban (Xarelto ... Over a dozen other generic manufacturers are also in line to ...

Janssen Pharms' Xarelto is prescribed to reduce the risk ... single-source drugs that didn't have generic or competitor versions to renegotiate under Biden's Inflation Reduction Act of 2022 ...

The United States Food and Drug Administration (USFDA) (Image Credits: Reuters) The United States Food and Drug Administration (USFDA) has approved the first generics of Xarelto (rivaroxaban ...

With sales of its top-selling product, blood thinner Xarelto, tumbling because of generic competition, Bayer isn’t projecting growth for the pharma division until 2027. Bayer’s pharma sales ...

Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients. The drug, marketed by ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2 ...